Is Psoriasis Treatment a Risk Factor for Inflammatory Bowel Disease?
Journal
Pharmaceutical medicine
ISSN: 1179-1993
Titre abrégé: Pharmaceut Med
Pays: New Zealand
ID NLM: 101471195
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
10
6
2020
medline:
4
6
2021
entrez:
10
6
2020
Statut:
ppublish
Résumé
Inflammatory bowel diseases-ulcerative colitis and Crohn's disease-are linked with several environmental and genetic risk factors. There are also known drugs able to induce de novo disease or to exacerbate its course. Several autoimmune disorders are more frequent in patients with inflammatory bowel diseases, including psoriasis. The aim of the presented review was to summarise current knowledge on the links between psoriasis therapy and inflammatory bowel diseases. The interleukin-17 inhibitors (secukinumab, brodalumab and ixekizumab) and tumour necrosis factor inhibitor (etanercept), have the potential to induce ulcerative colitis and Crohn's disease de novo or exacerbate existing but silent diseases. There is no evidence that other biologic agents used in psoriasis are lined with such risk. The biologic drugs for psoriasis differ in their potential to induce or worsen inflammatory bowel diseases. Currently, there are no recommendations in European guidelines to screen patients with psoriasis for inflammatory bowel diseases. However, based on available evidence, inflammatory bowel diseases should not be forgotten on in-depth diagnostics in patients with psoriasis.
Identifiants
pubmed: 32514931
doi: 10.1007/s40290-020-00340-1
pii: 10.1007/s40290-020-00340-1
pmc: PMC7427703
doi:
Substances chimiques
Antibodies, Monoclonal
0
Biological Factors
0
Dermatologic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
257-262Références
Nat Immunol. 2009 Jun;10(6):603-9
pubmed: 19448631
Clin Immunol. 2004 Jan;110(1):55-62
pubmed: 14962796
Joint Bone Spine. 2012 Oct;79(5):457-63
pubmed: 22088934
Am J Clin Dermatol. 2016 Feb;17(1):33-47
pubmed: 26649440
Br J Dermatol. 2016 Aug;175(2):273-86
pubmed: 26914406
J Crohns Colitis. 2017 Aug 1;11(8):905-920
pubmed: 28039310
Br J Dermatol. 2008 Aug;159 Suppl 2:2-9
pubmed: 18700909
Pediatr Dermatol. 2017 May;34(3):253-260
pubmed: 28211161
Aliment Pharmacol Ther. 2019 Aug;50(3):289-294
pubmed: 31267570
Clin Exp Dermatol. 2020 Apr;45(3):344-345
pubmed: 31854471
Rheumatol Int. 2018 Nov;38(11):2157-2162
pubmed: 30293157
Gastroenterology. 2011 May;140(6):1756-1767
pubmed: 21530742
Biomed Res Int. 2013;2013:983902
pubmed: 23971052
Br J Dermatol. 2017 Mar;176(3):741-751
pubmed: 27106510
Am J Gastroenterol. 2014 Nov;109(11):1728-38
pubmed: 25223575
Lancet. 2015 Aug 8;386(9993):541-51
pubmed: 26072109
J Am Acad Dermatol. 2018 Feb;78(2):383-394
pubmed: 29332708
Dig Dis Sci. 2016 Jun;61(6):1772-4
pubmed: 26728477
Br J Dermatol. 2012 Oct;167(4):717-24
pubmed: 22716185
Curr Med Res Opin. 2014 Dec;30(12):2515-21
pubmed: 25252590
J Am Acad Dermatol. 2017 Oct;77(4):667-674
pubmed: 28780364
Ann Rheum Dis. 2019 Apr;78(4):473-479
pubmed: 30674475
J Am Acad Dermatol. 2017 Jan;76(1):70-80
pubmed: 27707593
Lancet. 2017 Jun 10;389(10086):2317-2327
pubmed: 28551073
Biochem Biophys Res Commun. 2008 Dec 5;377(1):12-6
pubmed: 18796297
Ann Rheum Dis. 2015 Jul;74(7):1373-8
pubmed: 24658834
Postepy Dermatol Alergol. 2014 Aug;31(4):256-61
pubmed: 25254011
J Am Acad Dermatol. 2017 Mar;76(3):441-448.e2
pubmed: 28027825
J Eur Acad Dermatol Venereol. 2016 Nov;30(11):1957-1960
pubmed: 27358210
J Am Acad Dermatol. 2016 Jul;75(1):83-98.e4
pubmed: 27180926
J Eur Acad Dermatol Venereol. 2009 May;23(5):561-5
pubmed: 19207663
BMC Gastroenterol. 2019 Sep 5;19(1):162
pubmed: 31488067
Clin Drug Investig. 2019 Aug;39(8):799-803
pubmed: 31168691
Aliment Pharmacol Ther. 2019 Aug;50(4):373-385
pubmed: 31309607
Am J Gastroenterol. 2011 Jan;106(1):110-9
pubmed: 20808297
N Engl J Med. 2016 Jul 28;375(4):345-56
pubmed: 27299809
Aliment Pharmacol Ther. 2018 Jul;48(2):196-205
pubmed: 29869804
Clin Exp Dermatol. 2001 Jun;26(4):314-20
pubmed: 11422182
J Am Acad Dermatol. 2020 Feb;82(2):352-359
pubmed: 31175909
Am J Gastroenterol. 2016 Nov;111(11):1599-1607
pubmed: 27481309
Immunity. 2015 Oct 20;43(4):739-50
pubmed: 26431947
N Engl J Med. 2015 Oct;373(14):1318-28
pubmed: 26422722
J Exp Med. 2008 May 12;205(5):1063-75
pubmed: 18411338
Clin Dermatol. 2007 Nov-Dec;25(6):529-34
pubmed: 18021889
Am J Gastroenterol. 1990 Aug;85(8):962-3
pubmed: 2375323
Immunity. 2008 Apr;28(4):454-67
pubmed: 18400188
J Dermatol. 2017 Apr;44(4):355-362
pubmed: 27726163
Gut. 2012 Dec;61(12):1693-700
pubmed: 22595313
J Am Acad Dermatol. 2009 Sep;61(3):405-10
pubmed: 19700012
J Crohns Colitis. 2016 Mar;10(3):239-54
pubmed: 26614685
Case Rep Gastroenterol. 2018 Oct 17;12(3):617-621
pubmed: 30483039
ACG Case Rep J. 2018 Aug 1;5:e56
pubmed: 30105273
Clin Dermatol. 2014 May-Jun;32(3):343-50
pubmed: 24767182